Amber Molecular announced that it has completed its Series A funding round, raising $5 million USD, led by Phoenix Venture Partners.

Amber Molecular was established in 2017 by researchers at The University of Toronto in Canada to develop novel fluorescent OLED emitters. Amber Molecular's patented family of fluorescent OLED emissive materials produce photons in the orange, red and infrared spectrum, targeting new OLED applications.

Tags:
Cambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDsCambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDs